The FDA has announced the recall of one brand of a popular type 2 diabetes drug, metformin, over a potentially cancer-causing impurity. Viona Pharmaceuticals, Inc. is voluntarily recalling 23 lots ...

Two lots of a widely used type 2 diabetes medication, metformin, are being recalled due to possible contamination with a potentially cancer-causing compound. Metformin is designed to lower glucose ...

A voluntary recall of Metformin, a prescription medication for type 2 diabetes patients, has caused alarm among some Snopes readers, with many asking if the drug could cause cancer.

Primary Care > Diabetes Metformin Recalls Ballooned in 2020 — Last addition to the list in November brought number to 254 products recalled. by Kristen Monaco, Staff Writer, MedPage Today ...

NDMA Prompts Metformin Recall — FDA finds certain products with excessive levels of potential carcinogen by Kristen Monaco , Staff Writer, MedPage Today May 29, 2020 ...

The recall applies to metformin tablets between 500 mg and 750 mg, sold under the brand name Time-Cap Labs, Inc. The recall expands an earlier recall of the same product from this summer.

What metformin is recalled? Metformin Hydrochloride Extended-Release Tablets, USP 750 mg in 100-count bottles. Viona’s FDA-posted recall describes the tablets as “white to off-white, capsule ...

Metformin is used for managing blood glucose in adults with Type 2 diabetes mellitus. The recalled diabetes medication was packaged in HDPE bottles of 100 tablets under the NCD 72578-036-01.

The recall affects 76 lots of the medication sold in 500 mg and 750 mg dosages. The affected Metformin was packaged in high-density polyethylene bottles in 90, 100, 500, and 1,000 counts.

Apotex Corp.,expanded its recall of its Type 2 diabetes drug Metformin Hydrochloride because it could contain too much cancer carcinogen NDMA. Teva Pharmaceuticals and Marksans Pharma Limited also ...

An existing recall of popular diabetes medication metformin has been expanded over the presence of an impurity that may increase cancer risk. The expanded recall comes from Marksans Pharma Ltd ...

The metformin contamination follows recalls of heartburn med Zantac and "sartan" blood pressure drugs for the same carcinogen.. Valisure played a key role in all three of those major recall ...